Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,223 | -6,327 | -2,234 | -6,150 | -4,083 |
| Depreciation Amortization | N/A | N/A | N/A | 10 | N/A |
| Accounts payable and accrued liabilities | -29 | -51 | 3 | -188 | 20 |
| Other Working Capital | -896 | -923 | -465 | 151 | -158 |
| Other Operating Activity | 5,537 | 3,779 | 1,142 | 3,231 | 2,219 |
| Operating Cash Flow | $-4,610 | $-3,522 | $-1,554 | $-2,947 | $-2,002 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | N/A | -124 | -124 |
| Other Investing Activity | 0 | 0 | 0 | -124 | -124 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-124 | $-124 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,150 | 2,150 | 2,075 | 2,177 | 1,100 |
| Common Stock Issued | 11,900 | 11,894 | N/A | 175 | 175 |
| Other Financing Activity | -2,155 | -2,155 | -19 | 779 | 899 |
| Financing Cash Flow | $11,895 | $11,889 | $2,056 | $3,131 | $2,174 |
| Beginning Cash Position | 64 | 64 | 64 | 3 | 3 |
| End Cash Position | 7,348 | 8,431 | 566 | 64 | 51 |
| Net Cash Flow | $7,284 | $8,367 | $502 | $61 | $48 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,610 | -3,522 | -1,554 | -2,947 | -2,002 |
| Free Cash Flow | -4,610 | -3,522 | -1,554 | -2,947 | -2,002 |